CorePharma LLC

Overview

CorePharma LLC is a privately held pharmaceutical company based in Middlesex, New Jersey. Founded in 1998, it provides development, manufacturing, analytical, and packaging services for branded and generic pharmaceuticals, with a focus on oral solid dosage forms.

Contract services

• Development: Bench-scale formulation development for a range of dosage forms and complex niche formulations, scale-up and technology transfer, process validation and technical support, and analytical method development and validation.
• Analytical: Raw material testing, in-process testing, finished product testing, and stability testing.
• Manufacturing: Oral solid dosage tablets and capsules, with an annual capacity exceeding 2 billion dosage units. Listed capabilities include wet and dry granulation, drying, milling and blending, compression, aqueous film coating, and encapsulation. The site describes support from clinical pilot-scale batches through high-volume commercial manufacturing.
• Packaging: Contract packaging for oral solid dosage products, including bottle and blister packaging, along with blister and bottle cartoning.

Facilities and registrations

The company reports approximately 60,000 square feet of facilities and describes its development, testing, manufacturing, and packaging operations as state of the art. The site states that it is FDA and DEA registered for controlled substances (CII–CV). Facilities are listed at 215 Wood Avenue and 236/237 Lackland Drive in Middlesex, NJ.

Business focus

The company lists product development, contract manufacturing, contract packaging, analytical testing, and licensing among its business focus areas. Its public materials describe a quality-focused culture and a partnership-oriented approach to outsourced development and manufacturing.